Trials / Not Yet Recruiting
Not Yet RecruitingNCT06665321
Internet-based Affect Focused Psychodynamic Therapy for Neuroticism: a Randomized Controlled Trial
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 108 (estimated)
- Sponsor
- Linkoeping University · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to investigate if internet delivered affect-focused psychodynamic therapy (IPDT) leads to lowered levels of trait neuroticism compared to a wait-list control condition. The target group is adults (18+) who experience mild to moderate symptoms of anxiety and/or depression. The IPDT treatment consists of 8 modules that the participants will work with for 9 weeks, with therapist support. Participants will be recruited in Sweden with nationwide recruitment.
Detailed description
This study is a randomized controlled trial with the aim to investigate if IPDT leads to lowered levels of trait neuroticism. Participants will either be randomized to the treatment which is based on Affect Phobia Therapy or to a wait-list control. Participants will have weekly contact with a therapist who will provide feedback and support. Primary outcome measure is trait neuroticism (measured on the 24-Item Neuroticism scale of the IPIP-NEO-120). Secondary outcome measures will include measures of anxiety, depression, quality of life, emotion regulation, and defense mechanism adaptiveness. Emotion regulation and short measure of anxiety and depressive symptoms will be collected weekly throughout the treatment period. Pre-treatment measurement, post-treatment measurement, weekly measure, and one-year follow up is planned to be collected through an online survey.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Internet-based psychodynamic therapy (IPDT) | The intervention is 9 week long with weekly modules that the participants work with while receiving weekly support from an assigned therapist. |
Timeline
- Start date
- 2025-01-01
- Primary completion
- 2025-04-01
- Completion
- 2025-06-01
- First posted
- 2024-10-30
- Last updated
- 2024-11-12
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT06665321. Inclusion in this directory is not an endorsement.